Compare COO & DY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COO | DY |
|---|---|---|
| Founded | 1980 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Water Sewer Pipeline Comm & Power Line Construction |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 12.3B |
| IPO Year | 1994 | 1995 |
| Metric | COO | DY |
|---|---|---|
| Price | $70.19 | $486.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 10 |
| Target Price | $90.18 | ★ $425.30 |
| AVG Volume (30 Days) | ★ 3.5M | 590.5K |
| Earning Date | 05-28-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.71 |
| EPS | 0.27 | ★ 3.00 |
| Revenue | ★ $2,532,800,000.00 | N/A |
| Revenue This Year | $6.66 | $30.96 |
| Revenue Next Year | $5.18 | $9.49 |
| P/E Ratio | $254.70 | ★ $161.09 |
| Revenue Growth | ★ 18.41 | N/A |
| 52 Week Low | $58.89 | $233.00 |
| 52 Week High | $89.83 | $566.47 |
| Indicator | COO | DY |
|---|---|---|
| Relative Strength Index (RSI) | 66.45 | 59.42 |
| Support Level | $67.91 | $335.20 |
| Resistance Level | $72.59 | $490.00 |
| Average True Range (ATR) | 1.83 | 22.53 |
| MACD | 0.37 | -0.62 |
| Stochastic Oscillator | 81.50 | 81.07 |
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Dycom Industries Inc is a provider of specialty contracting services to the telecommunications infrastructure and utility industries throughout the United States. The company has two reporting segments: Communications and Building Systems. The Communications segment provides specialty contracting services, including program management, planning; engineering and design; aerial, underground, and wireless construction; maintenance; and fulfillment services for telecommunications and digital infrastructure providers. The Building Systems segment specializes in providing comprehensive building infrastructure solutions, including electrical, energy management, security, and fire safety systems for data centers and other critical facilities. The firm generates key revenue from Communications.